Tag Archives: FDLI symposium: special topics fda

FDLI symposium: special topics

Special Topics FDA Regulation of Genomic Testing and the First Amendment Barbara Evans, Professor, University of Houston Law Center   Of companies in clinical sequencing industry: 10 of 68 do sequencing only; 21 of 68 annotation and interpretation only. That … Continue reading

Posted in Uncategorized | Tagged , , | Leave a comment